Back to top

Elite Pharmaceuticals Reports Positive Anticonvulsant Bioequivalence Study

Elite Pharmaceuticals ( ($ELTP) ) has shared an update. On June 15, 2026, Elite Pharmaceuticals reported positive results from a pivotal bioequival...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: